Anti-neutrophil cytoplasmic autoantibodies in leprosy

British Journal of Rheumatology

Volumn 37, Issue 3, 1998, Pages 270-273

  Medina, F ^a,c   Camargo, A ^a   Moreno, J ^b   Zonana Nacach, A ^a   Aceves Avila, J ^a   Fraga, A ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c ISSFAM ^*  (Mexico)

Author keywords

Antineutrophil cytoplasmic antibodies; Leprosy

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BORDERLINE LEPROSY; CONTROLLED STUDY; CYTOPLASM; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DEFECT; TUBERCULOID LEPROSY;

EID: 0031823321     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.3.270     Document Type: Article

References (29)

1. Noorden SK, López Bravo L, Sundaresan TK. Estimated number of leprosy cases in the world. Bull WHO 1992;70:7-10.
2. Cossernilli-Messina W. Leprosy: statistics in the Americas. J Rheumatol 1993;20:893-6.
3. World Health Organization. Latest available statistics on leprosy. Geneva, Switzerland, June 1991.
4. Kamradt T. T cell unresponsiveness in lepromatous leprosy. J Rheumatol 1993;20:904-6.
5. Chávez-Legazpi M, Gómez-Vázquez A, García-De La Torre I. Study of rheumatic manifestations and serologic abnormalities in patients with lepromatous leprosy. J Rheumatol 1985;12:737-41.
6. Yenning MC, Quinn A, Broomhead V, Bird AG. Antibodies directed against neutrophils (c-ANCA and p-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med 1990;77:1287-96.
7. Nolle B, Specks U, Ludemann J, Rohrbach MS, De Remee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:1577-87.
8. Savige JA, Gallichio MC, Stockman A et al. Antineutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 1991;86:92-8.
9. Pauzner R, Urowitz M, Gladman D, Gough J. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 1994;21:1670-3.
10. Saxon A, Shanahan F, Landers C, Granz T, Targan S. A distinct subset of anti-neutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
11. Wichmann I, Sánchez-Román J, Morales J, Castillo MJ, Ocaña C, Núñez Roldán A. Antimyeloperoxidase antibodies in individuals with occupational exposure to silica. Ann Rheum Dis 1996;55:205-7.
12. Soto A, Jorgensen C, Oksman F, Noel LH, Sany J. Endocarditis associated with ANCA. Clin Exp Rheumatol 1994;12:203-4.
13. Pufidin DJ, Duurrsma J, Gathiram V, Jackson TF. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol 1994;12:48-51.
14. Locht H, Peen E, Skogh T. Antineutrophil cytoplasmic antibodies in reactive arthritis. J Rheumatol 1995; 22:2304-6.
15. Klaassen RJL, Goldschmeding R, Dolman KM et al. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992;87:24-30.
16. Galperin C, Shoenfeld Y, Gilburd B et al. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin Exp Rheumatol 1996;14:479-83.
17. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five group system. Int J Leprosy Other Mycobact Dis 1966;34:255-73.
18. Bloom BR. Learning for leprosy: a perspective on immunology and the third world. J Immunol 1986; 137:I-X.
19. Myrvan B, Godal T, Ridley DS, Froland SS, Song YK. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol 1973;14:541-9.
20. Petchclai B, Chuthanondh R, Rungroug S et al. Autoantibodies in leprosy among Thai patients. Lancet 1973;1:1481-2.
21. Sharma VK, Saha K, Sehgal VN. Serum immunoglobulins and autoantibodies during and after erythema nodosum leprosum. Int J Leprosy Other Mycobact Dis 1982;50:159-63.
22. Miller RA, Wener MH, Harnisch JP et al. The limited spectrum of antinuclear antibodies in leprosy. J Rheumatol 1987;14:108-10.
23. McAdam KP, Mudd D, Shoenfield Y et al. Autoantibodies to DNA in leprosy: Antigenic similarities between DNA and mycobacterial phospholipids defined by human monoclonal antibodies. Int J Leprosy Other Mycobact Dis 1984;52(suppl.):697.
24. Frey FLP, Gotlieb AB, Lewis AR. A patient with lepromatous leprosy and anticytoskeletal antibodies. J Am Acad Dermatol 1988;18:1179-84.
25. Esaguy N, Aguas AP, van Embden JDA, Silva MT. Mycobacteria and human autoimmune disease: Direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli. Infect Immun 1991;59:1117-25.
26. Jones DB, Coulson AFW, Duff GW. Sequence homologies between hsp 60 and autoantigens. Immunol Today 1993;14:115-8.
27. Ludemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990; 171:357-62.
28. Hagen EC, Ballieux BEP, Van Es LA, Daha MR, Van Der Would FJ. Anti-neutrophil cytoplasmic antibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenic consequences. Blood 1993;81:1996-2002.
29. McHugh NJ, Dunphy J, Rands A, Hill C. Antimyeloperoxidase antibodies in minocycline-induced lupus syndrome and myeloperoxidase dependent drug cytotoxicity. Arthritis Rheum 1996;39(suppl.):S110.